Type of secretions |
Watery secretions |
Thick tenacious mucin |
Discolored secretions |
Appearance of eosinophilic cells |
Intact eosinophilic cells |
Necrotic eosinophilic cells (ETosis) |
Mainly neutrophilic cells (NTosis) |
Charcot-Leyden crystals (CLC) |
No CLC |
CLC present |
No CLC |
Appearance of granules |
No granules, no proteins |
Granule proteins |
Free eosinophilic granules |
Type of cytokines |
T2 cytokines |
T2 cytokines |
T1 cytokines |
Typical age of patients |
Likely young population |
Likely older population |
Diverse |
IgE involvement |
Evidence of IgE-mediated |
IgE not necessarily present |
IgE not likely |
Presence of nasal polyps |
Nasal polyposis not likely |
Nasal polyposis likely |
(Small) nasal polyps possible |
State of mucosal lining |
No damage of mucosal lining |
Possible mucosal damage |
Possible mucosal damage |
Presence of hyphae |
No hyphae |
Hyphae possible |
Hyphae not likely |
Presence of major basic protein (MBP) |
No MBP |
MBP present |
MBP not likely |
CT appearance |
Typical black halo on CT |
Possible CT hyperattenuation |
Atypical sinusitis on CT |
Presence of asthma |
Asthma with early onset |
Late-onset asthma, eosinophilic |
Atypical asthma |
Possibility of oral steroids |
Oral steroids rarely |
Oral steroids more frequently |
Oral steroids rarely |
Possibility of vaccination |
Possible vaccination |
Vaccination rarely |
No vaccination considered |
Standard oral therapy |
Anti-allergic therapy |
Steroids, monoclonal antibodies |
Antibiotics |
Typical evolution |
Tendency to disappear with age |
Tendency to aggravate with age |
Aggravation with age (multifactorial) |
Persistence of disease |
Restricted lifetime pathology |
Lifetime pathology |
Multifactorial dependent lifetime |